5 Things You Should Know About Oncofertility

Here are five things you may not know about Oncofertility: 1. The word "Oncofertility" was coined by Dr. Teresa K. Woodruff of Northwestern University to define an area of academic research and practice that concerns both oncology and reproductive medicine. Oncofertility researchers and practitioners study fertility preservation options and are innovating new ways to help people who face impaired or reduced fertility rates due to cancer. 2. Cancer and its treatment can affect a person's ability to have children. 3. We still do not completely know or understand the barriers and why a hundred percent of eligible patients are not offered fertility preservation options prior to starting cancer treatment by their healthcare team. 4. It is the oncology staff's job to present fertility preservation options to the patient. However, it is not oncology staff who actually do the process to preserve the patient's fertility. It has to be done by reproductive endocrinologists/reproductive experts. 5. An Oncofertility consortium is being developed that will change the landscape of this field. Cancer and its treatment (surgery, chemotherapy and radiation) have the ability to affect a person's experience of sexuality from mild to debilitating in psychosocial (psychological + sociological) and physiological ways. One of these ways is through reducing or impairing the person's ability to have children. Despite this, fertility preservation options are not routinely presented to patie...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news

Related Links:

Authors: Dome P, Faludi G Abstract Main indications of antidepressants (ADs) as major depressive disorder (MDD) and different kinds of anxiety disorders are quite prevalent during pregnancy and the postpartum period. Due to the possible hazards of in utero and breast milk exposition of ADs, both psychiatrists and mothers frequently have concerns about the use of ADs during the periods of pregnancy and breastfeeding. However, we should also bear in mind that affective disorders left untreated during these periods are also associated with health risks for the mother and the baby as well. Accordingly, the treatment of...
Source: Neuropsychopharmacologia Hungarica - Category: Psychiatry Tags: Neuropsychopharmacol Hung Source Type: research
CONCLUSIONS: Fluorescein-guided surgery is a safe and effective technique to improve visualization and resection of different CNS tumors and conditions, based on BBB alteration, with a growing evidence-based background. PMID: 29790725 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgical Sciences - Category: Neurosurgery Tags: J Neurosurg Sci Source Type: research
CONCLUSION: GoC conversations may be facilitated by enabling oncologists to conduct these conversations despite difficult circumstances and emotional reactions by activating patients and family via increased health literacy and by advancing palliative-informed practice environments. PMID: 29790421 [PubMed - as supplied by publisher]
Source: Journal of Palliative Care - Category: Palliative Care Tags: J Palliat Care Source Type: research
The World Cancer Research Fund (WCRF) has bad news for lovers of bacon and booze: Eliminating processed meats and alcohol from your diet may help reduce your risk of developing cancer. The third report from the WCRF’s Continuous Update Project, an ongoing effort to inform consumers about lifestyle habits that may be related to cancer, provides numerous recommendations for people looking to minimize their risk of getting cancer. But two, in particular, are likely to cause a stir for many Americans. First, the WCRF recommends significantly or totally cutting back on processed meats including bacon, salami, hot dogs and...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Cancer healthytime onetime Source Type: news
Contributors : Duhen Thomas ; Montler Ryan ; Weinberg AndrewSeries Type : Expression profiling by arrayOrganism : Homo sapiensIdentifying tumor antigen-specific T cells from cancer patients has been a goal of tumor immunologists for several decades. Co-expression of CD103 and CD39 on CD8 TIL highly enriches for tumor-reactive T cells. CD39+CD103+ CD8 TIL have a distinct TCR repertoire compared to other CD8 TIL subsets and are clonally expanded within the tumor.They are highly enriched for tumor antigen recognition and efficiently killed autologous tumor cells. Patients with head and neck cancer whose CD8 TIL contained a hi...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Homo sapiens Source Type: research
A Times newspaper investigation found the NHS was charged £3,220 for a mouthwash used by cancer patients.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
This article explores the causes of brown discharge, and when to see a doctor.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Women's Health / Gynecology Source Type: news
(Natural News) The Budwig diet has been around for more than 50 years — and it may be the best anti-cancer diet you’ve never heard of before. Developed by the late Dr. Johanna Budwig, an esteemed chemist from Germany and a 7-time Nobel prize nominee, the diet centers on two key health-boosting foods. Is that...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Authors: Smith KM, Desai J Abstract INTRODUCTION: Despite a variety of therapies for advanced metastatic colorectal cancer being available, the outcomes in this malignancy remain sub-optimal. Immunotherapy has been slow to impact the management of this patient group. Checkpoint inhibitors, such as nivolumab, have had disappointing results when used broadly. However, for the subset of patients with microsatellite unstable colorectal cancer the use of checkpoint inhibitors such as nivolumab appears to be transformative, and will provide a new therapeutic option for patient with advanced disease. Areas covered: Nivolu...
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research
Authors: Brandão M, Pondé NF, Poggio F, Kotecki N, Salis M, Lambertini M, de Azambuja E Abstract INTRODUCTION: HER2-positive disease is an aggressive subtype of breast cancer that has been revolutionized by anti-HER2 directed therapies. Multiple drugs have been developed and are currently in clinical use, including trastuzumab, lapatinib, pertuzumab, T-DM1, and neratinib, alone or combined in 'dual HER2-blockade' regimens. Areas covered: A comprehensive literature review was performed regarding the current state and the future of combination regimens containing anti-HER2 agents, focusing on their effi...
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research
More News: Academia | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Chemotherapy | Children | Conferences | Endocrinology | Health | Hospital Management | Hospitals | Infertility | Learning | Lymphoma | Neurology | Parenting | Pediatrics | Pregnancy | Psychology | Reproduction Medicine | Study | Universities & Medical Training | Websites | Workshops